The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Induction mFOLFOX6 with or without aflibercept followed by chemoradiation (CRT) and surgery in high risk rectal cancer: Phase II randomized, multicenter, openlabel trial—The GEMCAD RIA study.
 
Carlos Fernandez-Martos
No Relationships to Disclose
 
Vicente Alonso
Consulting or Advisory Role - Merck; Roche Pharma AG; Sanofi
 
Isabel Busquier
No Relationships to Disclose
 
Jaume Capdevila
No Relationships to Disclose
 
Antonio Cubillo Gracian
No Relationships to Disclose
 
Javier Gallego Plazas
No Relationships to Disclose
 
Inmaculada Guasch
No Relationships to Disclose
 
Laura Layos
No Relationships to Disclose
 
Ferran Losa
No Relationships to Disclose
 
Juan Maurel
No Relationships to Disclose
 
Marta Martin-Richard
No Relationships to Disclose
 
Mercedes Martinez Villacampa
No Relationships to Disclose
 
Bartomeu Massuti
No Relationships to Disclose
 
Clara Montagut Viladot
No Relationships to Disclose
 
Miquel Nogue
No Relationships to Disclose
 
Carles Pericay
No Relationships to Disclose
 
Maria Jose Safont
No Relationships to Disclose
 
Nuria Salas
No Relationships to Disclose
 
Antonieta Salud Salvia
No Relationships to Disclose
 
Ruth Vera
No Relationships to Disclose